Reuters Health News

Reuters News is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 1 hour 32 min ago

$11 billion biotech binge fuels forecasts of 2018 M&A surge

January 8, 2018 - 10:05am
LONDON (Reuters) - An $11 billion burst of biotech bids in just four days has fueled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.
Categories: Consumer Health News

Sanofi and Regeneron boost investment in cancer drug cemiplimab

January 8, 2018 - 8:58am
PARIS (Reuters) - France's Sanofi and U.S Regeneron said on Monday they would inject an additional $1 billion in the development of cemiplimab, an antibody that could, if successful, be used to treat a wide range of cancers.
Categories: Consumer Health News

Axovant to scrap intepirdine program after dementia trial fails

January 8, 2018 - 7:30am
(Reuters) - Axovant Sciences Ltd said on Monday it would discontinue its intepirdine program after the experimental treatment failed in a mid-stage study on patients suffering from a type of dementia.
Categories: Consumer Health News

Death toll in South Africa listeria outbreak jumps to 61

January 8, 2018 - 7:23am
JOHANNESBURG (Reuters) - The death toll from an outbreak of listeria in South Africa has jumped beyond 60 in the past month, health authorities said on Monday, adding they had closed a poultry abattoir where the bug that causes the disease had been detected.
Categories: Consumer Health News

Regeneron forms consortium to accelerate gene sequencing project

January 8, 2018 - 7:03am
(Reuters) - Regeneron Pharmaceuticals Inc on Monday announced a collaboration with rival drugmakers that will speed its effort to collect genetic information on 500,000 people in the UK Biobank database, a project it believes could help accelerate new drug discovery and improve approval success rates.
Categories: Consumer Health News

Pfizer ends research for new Alzheimer's, Parkinson's drugs

January 8, 2018 - 7:01am
NEW YORK (Reuters) - Pfizer Inc is abandoning research to find new drugs aimed at treating Alzheimer's and Parkinson's disease, the U.S. pharmaceutical company announced on Saturday.
Categories: Consumer Health News

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

January 8, 2018 - 2:03am
(Reuters) - Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday.
Categories: Consumer Health News

Sanofi to market new hemophilia drug in deal with Alnylam

January 8, 2018 - 2:02am
PARIS (Reuters) - French pharmaceutical group Sanofi said it has obtained the right to develop and sell a new hemophilia drug in a restructuring of its partnership with U.S. Alnylam Pharmaceuticals.
Categories: Consumer Health News

Zambia declares curfew in Lusaka slum struck by cholera

January 7, 2018 - 10:38am
LUSAKA (Reuters) - Zambia has declared a curfew in a poor Lusaka township badly affected by a cholera outbreak that has killed 58 people across the country since September, the government said on Sunday.
Categories: Consumer Health News

Court voids Baltimore law requiring 'no abortion' clinic disclaimers

January 5, 2018 - 4:49pm
(Reuters) - A federal appeals court on Friday declared unconstitutional a Baltimore law requiring pregnancy clinics that do not offer or refer women for abortions to post signs disclosing that fact in their waiting rooms.
Categories: Consumer Health News

ADHD drug tied to heart defects in babies

January 5, 2018 - 4:10pm
(Reuters Health) - - Pregnant women who take drugs like Ritalin and Concerta for attention deficit hyperactivity disorder (ADHD) are more likely than those who don’t to have babies with heart deformities and other birth defects, a recent study suggests.
Categories: Consumer Health News

Smokers more likely to need spinal surgery

January 5, 2018 - 3:24pm
(Reuters Health) - - Smoking increases the risk of lower back pain that needs to be fixed by spinal surgery, a Swedish study suggests.
Categories: Consumer Health News

Brazil expects to be declared free of foot-and-mouth with vaccination

January 5, 2018 - 2:48pm
BRASILIA (Reuters) - Brazil expects the World Organisation for Animal Health (OIE) to declare the country free from foot-and-mouth disease with vaccinations at a meeting in May, according to a government statement on Friday.
Categories: Consumer Health News

Twice-weekly workouts may be best medicine for cognitive decline

January 5, 2018 - 2:01pm
(Reuters Health) - - There’s little evidence that medications improve mild cognitive decline associated with aging, according to a new review of research, but doctors can recommend exercise with confidence.
Categories: Consumer Health News

Drug charity halts patient aid after U.S. health agency pulls approval

January 5, 2018 - 1:52pm
BOSTON (Reuters) - One of the largest patient assistance charities in the United States said it will not provide financial aid in 2018 after the government revoked its approval to do so because of concerns that drugmakers had improper influence over the charity.
Categories: Consumer Health News

Hungary's Richter expects Esmya drug ruling in first half: CEO

January 5, 2018 - 11:57am
BUDAPEST (Reuters) - Hungarian drugmaker Richter expects European health inspectors to deliver a ruling on its Esmya medicine in the first half of 2018, its chief executive told Reuters, adding that uncertainty about the drug could delay earnings guidance.
Categories: Consumer Health News

Can living near a gym make you slimmer?

January 5, 2018 - 11:44am
(Reuters Health) - People who live close to gyms, pools and playing fields weigh less and have smaller waistlines than their counterparts residing farther away from exercise facilities, a UK study suggests.
Categories: Consumer Health News

FDA expands use of Amgen's blockbuster drug

January 5, 2018 - 10:48am
(Reuters) - Amgen Inc said on Friday that the U.S. Food and Drug Administration approved its drug, Xgeva, to prevent fractures in patients with multiple myeloma.
Categories: Consumer Health News

Future of Kala Pharma's dry eye drug uncertain after mixed results

January 5, 2018 - 9:48am
(Reuters) - Mixed results from two late-stage studies testing Kala Pharmaceuticals Inc's drug to provide temporary relief from dry eye disease cast doubt on the drug's path forward and sent shares down 16 percent in early trading on Friday.
Categories: Consumer Health News

Trump administration drops Obama-era easing of marijuana prosecutions

January 4, 2018 - 7:55pm
WASHINGTON (Reuters) - The U.S. Justice Department on Thursday rescinded an Obama administration policy that had eased enforcement of federal marijuana laws in states that legalized the drug, instead giving federal prosecutors wide latitude to pursue criminal charges.
Categories: Consumer Health News